Visceral leishmaniasis as an AIDS defining condition: towards consistency across WHO guidelines.

Visceral leishmaniasis as an AIDS defining condition: towards consistency across WHO guidelines.

Bibliographic Details
Main Authors:	Johan van Griensven, Koert Ritmeijer, Lutgarde Lynen, Ermias Diro
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2014-07-01
Series:	PLoS Neglected Tropical Diseases
Online Access:	http://europepmc.org/articles/PMC4102411?pdf=render

Similar Items

Visceral Leishmaniasis and HIV coinfection in East Africa.
by: Ermias Diro, et al.
Published: (2014-06-01)

A screen-and-treat strategy targeting visceral leishmaniasis in HIV-infected individuals in endemic East African countries: the way forward?
by: Johan van Griensven, et al.
Published: (2014-08-01)

High parasitological failure rate of visceral leishmaniasis to sodium stibogluconate among HIV co-infected adults in Ethiopia.
by: Ermias Diro, et al.
Published: (2014-05-01)

Development and external validation of a clinical prognostic score for death in visceral leishmaniasis patients in a high HIV co-infection burden area in Ethiopia.
by: Charles Abongomera, et al.
Published: (2017-01-01)

Bacterial Sepsis in Patients with Visceral Leishmaniasis in Northwest Ethiopia
by: Mengistu Endris, et al.
Published: (2014-01-01)

The initial effectiveness of liposomal amphotericin B (AmBisome) and miltefosine combination for treatment of visceral leishmaniasis in HIV co-infected patients in Ethiopia: A retrospective cohort study.
by: Charles Abongomera, et al.
Published: (2018-05-01)

Impact of the use of a rapid diagnostic test for visceral leishmaniasis on clinical practice in Ethiopia: a retrospective study.
by: Ermias Diro, et al.
Published: (2015-05-01)

Use of Pentamidine As Secondary Prophylaxis to Prevent Visceral Leishmaniasis Relapse in HIV Infected Patients, the First Twelve Months of a Prospective Cohort Study.
by: Ermias Diro, et al.
Published: (2015-01-01)

Leishmania Antigenuria to Predict Initial Treatment Failure and Relapse in Visceral Leishmaniasis/HIV Coinfected Patients: An Exploratory Study Nested Within a Clinical Trial in Ethiopia
by: Johan van Griensven, et al.
Published: (2018-03-01)

Multiple Relapses of Visceral Leishmaniasis in HIV Co-Infected Patients: A Case Series from Ethiopia
by: Rezika Mohammed, et al.
Published: (2020-01-01)

Bacterial sepsis in patients with visceral leishmaniasis in Northwest Ethiopia
by: M.E. Seid, et al.
Published: (2014-04-01)

Shigella Bacteremia in a Patient with Visceral Leishmaniasis
by: Mengistu Endris, et al.
Published: (2013-01-01)

Acute kidney injury in patients with Visceral Leishmaniasis in Northwest Ethiopia.
by: Workagegnehu Hailu, et al.
Published: (2021-01-01)

Abdominal ultrasound in the diagnostic work-up of visceral leishmaniasis and for detection of complications of spleen aspiration.
by: Rezika Mohammed, et al.
Published: (2021-02-01)

Characteristics of bacterial sepsis among patients with visceral leishmaniasis
by: Mengistu Endris, et al.
Published: (2014-11-01)

Host transcriptomic signature as alternative test-of-cure in visceral leishmaniasis patients co-infected with HIV
by: Wim Adriaensen, et al.
Published: (2020-05-01)

Outcomes of visceral leishmaniasis in pregnancy: A retrospective cohort study from South Sudan.
by: Judith E Pekelharing, et al.
Published: (2020-01-01)

A clinical severity scoring system for visceral leishmaniasis in immunocompetent patients in South Sudan.
by: Suzette S Kämink, et al.
Published: (2017-10-01)

Serum Levels of Soluble CD40 Ligand and Neopterin in HIV Coinfected Asymptomatic and Symptomatic Visceral Leishmaniasis Patients
by: Wim Adriaensen, et al.
Published: (2018-12-01)

Visceral leishmaniasis in AIDS patient
by: E. L. Nicodemo, et al.
Published: (1990-08-01)

Visceral leishmaniasis and HIV coinfection: time for concerted action.
by: Johan van Griensven, et al.
Published: (2014-08-01)

Accounting for False Positive HIV Tests: Is Visceral Leishmaniasis Responsible?
by: Leslie Shanks, et al.
Published: (2015-01-01)

Long term outcomes and prognostics of visceral leishmaniasis in HIV infected patients with use of pentamidine as secondary prophylaxis based on CD4 level: a prospective cohort study in Ethiopia.
by: Ermias Diro, et al.
Published: (2019-02-01)

Treatment of Cutaneous Leishmaniasis Caused by Leishmania aethiopica: A Systematic Review.
by: Johan van Griensven, et al.
Published: (2016-03-01)

Visceral leishmaniasis relapse in Southern Sudan (1999-2007): a retrospective study of risk factors and trends.
by: Stanislaw Gorski, et al.
Published: (2010-01-01)

HIV/AIDS-related visceral leishmaniasis: a clinical and epidemiological description of visceral leishmaniasis in northern Brazil
by: Leonardo Cordenonzi Pedroso de Albuquerque, et al.
Published: (2014-01-01)

Effectiveness and safety of short course liposomal amphotericin B (AmBisome) as first line treatment for visceral leishmaniasis in Bangladesh.
by: Emiliano Lucero, et al.
Published: (2015-04-01)

Evaluation of the 2007 WHO guideline to improve the diagnosis of tuberculosis in ambulatory HIV-positive adults.
by: Olivier Koole, et al.
Published: (2011-01-01)

Determinants of Visceral Leishmaniasis: A Case-Control Study in Gedaref State, Sudan.
by: Fabienne Nackers, et al.
Published: (2015-11-01)

Cutaneous Leishmaniasis Due to Leishmania aethiopica
by: Saskia van Henten, et al.
Published: (2018-12-01)

Presentation of AIDS with Disseminated Cutaneous and Visceral Leishmaniasis in Iran
by: Mohammadali Davarpanah, et al.
Published: (2015-01-01)

Immunity to Visceral Leishmaniasis Using Genetically Defined Live-Attenuated Parasites
by: Angamuthu Selvapandiyan, et al.
Published: (2012-01-01)

Immunomodulatory Therapy of Visceral Leishmaniasis in Human Immunodeficiency Virus-Coinfected Patients
by: Wim Adriaensen, et al.
Published: (2018-01-01)

Abdomen agudo en paciente VIH por Leishmaniasis visceral Acute abdominal pain due to visceral Leishmaniasis in an AIDS patient
by: I. Pascual, et al.
Published: (2007-01-01)

Severe post-kala-azar dermal leishmaniasis successfully treated with miltefosine in an Ethiopian HIV patient
by: Charles Abongomera, et al.
Published: (2019-04-01)

Visceral leishmaniasis and HIV/AIDS in Brazil: Are we aware enough?
by: Marcia Leite de Sousa-Gomes, et al.
Published: (2017-09-01)

A defined subunit vaccine that protects against vector-borne visceral leishmaniasis
by: Malcolm S. Duthie, et al.
Published: (2017-08-01)

Defining the role of tumour necrosis factor family members in murine visceral leishmaniasis
by: Alexander, Clare Elizabeth
Published: (2004)

A randomized trial of AmBisome monotherapy and AmBisome and miltefosine combination to treat visceral leishmaniasis in HIV co-infected patients in Ethiopia.
by: Ermias Diro, et al.
Published: (2019-01-01)

Diagnostic accuracy of direct agglutination test, rK39 ELISA and six rapid diagnostic tests among visceral leishmaniasis patients with and without HIV coinfection in Ethiopia.
by: Mekibib Kassa, et al.
Published: (2020-12-01)